Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Oct 30, 2014 · 10-Q · 30 days after period end · 0001193125-14-389643
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$4.91M | -$10.05M | -$5.92M | $4.47M |
| EPS Diluted | -$0.23 | -$0.68 | $0.40 | $0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Oct 30, 2014 · 30 d after period end
